|
| Tuesday, June 14, 2022 |
|
|
Olympus to Use 100% Renewable Electricity at R&D and Manufacturing Sites in Japan |
| Olympus Corporation ("Olympus" - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announces that from April 2022, the company has begun to exclusively source 100% of the electricity used at its major R&D and manufacturing sites in Japan from renewable sources. more info >> |
|
| Thursday, December 2, 2021 |
|
|
Olympus Selected for Inclusion in Dow Jones Sustainability World Index (DJSI World) |
| Olympus Corporation ("Olympus" - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) has been selected for inclusion in the 2021 Dow Jones Sustainability World Index (DJSI World) and the 2021 Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), among the world's most recognized corporate sustainability indices. Olympus is admitted to the DJSI World for the first time this year and in the DJSI Asia Pacific for the third consecutive year. more info >> |
|
| Friday, November 12, 2021 |
|
|
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership |
| Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has announced the establishment of Olympus Innovation Ventures to invest in pioneering startups with innovative technologies that improve clinical outcomes, reduce healthcare costs and enhance the quality of life for patients. more info >> |
|
| Tuesday, September 21, 2021 |
|
|
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices |
| more info >> |
|
|
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices |
| Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of the first devices in the new POWERSEAL(TM) family of advanced bipolar surgical energy products. more info >> |
|
| Thursday, April 8, 2021 |
|
|
Olympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Business |
| Olympus Corporation announced today the opening of a new facility in Westborough, MA, to serve as the global headquarters for its Therapeutic Solutions Division (TSD) and its medical business in the United States. more info >> |
|
| Thursday, February 4, 2021 |
|
|
Olympus Supports Dissemination of Endoscopic Procedures for Colorectal Cancer in Russia |
| Olympus Corporation announced today that it has been selected by Japan's Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021. more info >> |
|
| Monday, February 1, 2021 |
|
|
Olympus launches comprehensive global educational platform for healthcare professionals |
| Olympus Corporation has announced the launch of a new comprehensive educational platform designed to provide healthcare professionals (HCPs) all over the world with learning opportunities and training to put their skills into practice and keep them performing at their best. more info >> |
|
| Friday, January 29, 2021 |
|
|
Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities |
| Olympus Corporation has announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities. more info >> |
|
| Thursday, January 28, 2021 |
|
|
Olympus erwirbt niederländischen Fluoreszenz-Imaging-Spezialisten Quest Photonic Devices B.V. zwecks Erweiterung chirurgischer Endoskopie |
| Olympus Corporation gab heute bekannt, dass das Unternehmen eine Vereinbarung zur Übernahme von Quest Photonic Devices B.V. für einen Gesamtbetrag von ca. 50 Mio. Euro, einschließlich Meilensteinzahlungen, abgeschlossen hat. more info >> |
|
|
|
|
